Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Quantin

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Journal for Immunotherapy of Cancer|July 24, 2021
Neutrophils in the era of immune checkpoint blockadeJulien Faget, Solange Peters, Xavier Quantin, et al.
Cancers|February 13, 2026
Neoadjuvant Pembrolizumab Associated with Chemotherapy in Early Triple-Negative Breast Cancer Patients: Real-World Data from a French Single-Center ExperienceIchrak Ben Abdallah, Severine Guiu, Xavier Quantin, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2002
Combination chemotherapy without cisplatin in the treatment of advanced non-small cell lung cancerJean-Louis Pujol, Xavier Quantin, Didier Choma, et al.
American Journal of Clinical Oncology|February 3, 2005
Multimodality treatment program in invasive thymic epithelial tumorWilliam Jacot, Xavier Quantin, Sarah Valette, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 29, 2013
Smoking cessation, depression, and exercise: empirical evidence, clinical needs, and mechanismsPaquito Bernard, Gregory Ninot, Gregory Moullec, et al.
Bulletin Du Cancer|September 11, 2024
[Auto-inflammatory reaction triggered by Nivolumab: A case of adult-onset Still's disease-like syndrome]Stéphanie Hermabessière, Pascale Palassin, Xavier Quantin, et al.
International Journal of Molecular Sciences|March 29, 2023
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the KeyQuentin Dominique Thomas, Nelly Firmin, Litaty Mbatchi, et al.
Translational Lung Cancer Research|January 10, 2022
EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcomeJulie A Vendrell, Xavier Quantin, Audrey Aussel, et al.
La Revue Du Praticien|July 26, 2003
[Small cell lung carcinoma]Jean-Louis Pujol, Xavier Quantin, William Jacot, et al.
Journal of Affective Disorders|December 26, 2012
Self-reported major depressive symptoms at baseline impact abstinence prognosis in smoking cessation program. A one-year prospective studyGuillaume Fond, Sebastien Guillaume, Sylvaine Artero, et al.
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Journal for Immunotherapy of Cancer|July 24, 2021
Neutrophils in the era of immune checkpoint blockadeJulien Faget, Solange Peters, Xavier Quantin, et al.
Cancers|February 13, 2026
Neoadjuvant Pembrolizumab Associated with Chemotherapy in Early Triple-Negative Breast Cancer Patients: Real-World Data from a French Single-Center ExperienceIchrak Ben Abdallah, Severine Guiu, Xavier Quantin, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2002
Combination chemotherapy without cisplatin in the treatment of advanced non-small cell lung cancerJean-Louis Pujol, Xavier Quantin, Didier Choma, et al.
American Journal of Clinical Oncology|February 3, 2005
Multimodality treatment program in invasive thymic epithelial tumorWilliam Jacot, Xavier Quantin, Sarah Valette, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|March 29, 2013
Smoking cessation, depression, and exercise: empirical evidence, clinical needs, and mechanismsPaquito Bernard, Gregory Ninot, Gregory Moullec, et al.
Bulletin Du Cancer|September 11, 2024
[Auto-inflammatory reaction triggered by Nivolumab: A case of adult-onset Still's disease-like syndrome]Stéphanie Hermabessière, Pascale Palassin, Xavier Quantin, et al.
International Journal of Molecular Sciences|March 29, 2023
Combining Three Tyrosine Kinase Inhibitors: Drug Monitoring Is the KeyQuentin Dominique Thomas, Nelly Firmin, Litaty Mbatchi, et al.
Translational Lung Cancer Research|January 10, 2022
EGFR-dependent mechanisms of resistance to osimertinib determined by ctDNA NGS analysis identify patients with better outcomeJulie A Vendrell, Xavier Quantin, Audrey Aussel, et al.
La Revue Du Praticien|July 26, 2003
[Small cell lung carcinoma]Jean-Louis Pujol, Xavier Quantin, William Jacot, et al.
Journal of Affective Disorders|December 26, 2012
Self-reported major depressive symptoms at baseline impact abstinence prognosis in smoking cessation program. A one-year prospective studyGuillaume Fond, Sebastien Guillaume, Sylvaine Artero, et al.
Pageof 9